How Toy was paid
$1.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Andrew ToyCo-Founder and Chief Executive Officer | $800,000 | — | $509,539 | — | $9,846 | $1,319,385 |
| Peter KuipersChief Financial Officer | $525,000 | $1,175,929 | — | $344,138 | — | $2,045,067 |
| Jamie L. ReynosoChief Executive Officer of Medicare Advantage | $550,001 | $904,626 | — | — | $13,539 | $1,468,166 |
| Conrad WaiChief Executive Officer of Counterpart Health | $495,000 | $704,461 | — | — | $12,477 | $1,211,938 |
| Brady PriestChief Executive Officer of Clover Care Services | $495,000 | $704,461 | — | — | — | $1,199,461 |
What changed and why
- $1.3MCEO total compensation decreased to $1,319,385 in 2025 from $9,476,723 in 2024 primarily because no equity awards were granted to the CEO in 2025.
- Peter Kuipers served as Chief Financial Officer during 2025 before being succeeded by Clay Thornton in March 2026.
- $800KAnnualized base salaries were set at $800,000 for the CEO and ranged from $495,000 to $550,001 for other named executive officers.
- The compensation program incorporates variable performance-based annual cash bonus awards and long-term incentive programs designed to align with stockholder interests.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.